Search

Displaying results 5061 - 5070 of 10000 in total
  1. Drug

    Activated charcoal

    go.drugbank.com/drugs/DB09278
    ApprovedInvestigational

    The clinical applications of activated charcoal occured in the early 1800's. … It is activated by an oxidizing gas flow at high temperature passed over its surface to make a fine network of pores, producing a material with large surface area and high affinity for various substances

    Mixtures: FINIGAX®, FINIGAX® CAPSULASCategories: Compounds used in a research, industrial, or household setting
  2. Drug

    Gantenerumab

    go.drugbank.com/drugs/DB12034
    Investigational

    [A244705, A244710, A244745] Gantenerumab is a fully human IgG1κ monoclonal antibody derived from the MorphoSys HuCAL®-Fab1 phage display library and subsequently optimized by _in vitro_ CDR cassette … Alzheimer's disease (AD) is the most common cause of dementia in elderly patients, with classical histopathological hallmarks including extracellular amyloid-beta (Aβ) plaques and intraneuronal neurofibrillary

  3. Drug

    Cobamamide

    go.drugbank.com/drugs/DB11191
    ApprovedNutraceutical

    This drug is available as a nutritional supplement to prevent vitamin B12 deficiency. Vitamin B12 is a collective term for these variously substituted corrinoids. … There has been a shift in the treatment of vitamin B12 deficiency such that MeCbl is being extensively used and promoted.

    Categories: Vitamin B Complex, Heterocyclic Compounds, 1-RingSynonyms: 5'-Deoxy-5'-adenosylcobalamin, Coenzyme B-12
  4. Drug

    PA-1050040

    go.drugbank.com/drugs/DB06039
    Experimental

    PA1050040, a second generation HIV-1 maturation inhibitor, is a chemical analog of Bevirimat (BVM). It inhibits virus replication by the same mechanism of action as BVM.

  5. Drug

    Nafithromycin

    go.drugbank.com/drugs/DB16246
    Investigational

    Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin in CABP).

    Categories: Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors
  6. Drug

    Pegsunercept

    go.drugbank.com/drugs/DB06611
    Investigational

    Pegsunercept is used for treating rheumatoid arthritis. Phase II clinical trials were completed in January 2010.

    Categories: Compounds used in a research, industrial, or household settingSynonyms: sTNF-R1
  7. Drug

    Rumex salicifolius var. mexicanus pollen

    go.drugbank.com/drugs/DB10902
    Approved

    Rumex salicifolius var. mexicanus pollen is the pollen of the Rumex salicifolius var. mexicanus plant. Rumex salicifolius var. mexicanus pollen is mainly used in allergenic testing.

  8. Drug

    Salix lucida ssp. lasiandra pollen

    go.drugbank.com/drugs/DB10916
    Approved

    Salix lucida ssp. lasiandra pollen is the pollen of the Salix lucida ssp. lasiandra plant. Salix lucida ssp. lasiandra pollen is mainly used in allergenic testing.

  9. Drug

    Sorghum bicolor subsp. bicolor pollen

    go.drugbank.com/drugs/DB10965
    Approved

    Sorghum bicolor subsp. bicolor pollen is the pollen of the Sorghum bicolor subsp. bicolor plant. Sorghum bicolor subsp. bicolor pollen is mainly used in allergenic testing.

  10. Drug

    Sorghum bicolor subsp. drummondii pollen

    go.drugbank.com/drugs/DB10966
    Approved

    Sorghum bicolor subsp. drummondii pollen is the pollen of the Sorghum bicolor subsp. drummondii plant. Sorghum bicolor subsp. drummondii pollen is mainly used in allergenic testing.